<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Durable Complete Remission With Combination of Stereotactic Body Radiation Therapy (SBRT) and Talimogene Laherparepvec (TVEC) Followed by Ipilimumab in Refractory Metastatic Melanoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Durable Complete Remission With Combination of Stereotactic Body Radiation Therapy (SBRT) and Talimogene Laherparepvec (TVEC) Followed by Ipilimumab in Refractory Metastatic Melanoma." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596194/bin/cureus-0014-00000029573-i02.jpg"/> </div> <div class="text-side"> <h1>Durable Complete Remission With Combination of Stereotactic Body Radiation Therapy (SBRT) and Talimogene Laherparepvec (TVEC) Followed by Ipilimumab in Refractory Metastatic Melanoma.</h1> <p>Pathology.(A) H&amp;E-stained section showing a heavy infiltrate of pigmented cells in the dermis in perivascular and perifollicular distribution, magnification 2x. (B) Their bland cytology and coarse melanin granules, magnification 20x. (C) Immunostain for Mart (melanoma marker) is negative, magnification 4x (note: endogenous melanin pigment has been removed for immunostain study). (D) Immunostain for CD68 (histiocyte marker) is diffusely positive in the same area, confirming that pigmented cells are melanophages (melanin-laded macrophages), magnification 4x.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36312666/" target="_blank">36312666</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>